Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
about
Lipoexpediency: de novo lipogenesis as a metabolic signal transmitterThe protein kinase IKKepsilon regulates energy balance in obese miceSelective Insulin Resistance in the KidneyDietary approach in the treatment of nonalcoholic fatty liver diseaseThe role of fatty acids in insulin resistance'Micro-managers' of hepatic lipid metabolism and NAFLDUse of rodents as models of human diseasesNonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver diseaseThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseGenetically modified mouse models for the study of nonalcoholic fatty liver diseaseModulation of hepatic steatosis by dietary fatty acidsExposure to ambient air particulate matter and non-alcoholic fatty liver diseaseAlteration of energy substrates and ROS production in diabetic cardiomyopathy20 years of fatty acid analysis by capillary electrophoresisDietary protein affects gene expression and prevents lipid accumulation in the liver in miceSystematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver diseaseMetabolic effects of smoking cessationHow Inflammation Impinges on NAFLD: A Role for Kupffer CellsHigh susceptibility to fatty liver disease in two-pore channel 2-deficient miceRegressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat DietLong-term supplementation with a cystine-based antioxidant delays loss of muscle mass in agingA cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophenIncreased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthaseChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceProtective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal womenMangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPKCOH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese miceRapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth RetardationSmall molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humansDiacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in ratsLiver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosisNCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinomaA krill oil supplemented diet suppresses hepatic steatosis in high-fat fed ratsGlucose transporters in the 21st CenturyPromising therapies for treatment of nonalcoholic steatohepatitis.Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.
P2860
Q24620189-AF22E820-B9FC-483F-B68C-E11058D62BC5Q24658201-81904F63-7753-4408-8646-6A20AE02416AQ26744243-880289A2-57ED-47D3-B07A-43651E51E0F7Q26777508-54406FED-C54E-4A22-ABF5-0F5F4F8E50ECQ26785440-04CDD264-1294-4B4A-8978-F4D7F43049DBQ26801228-EA4D0EF4-A7C6-42C5-B0A9-8478D4D9DDE2Q26822856-EE3323FD-FD1B-4374-81AF-FB19D558696EQ26827169-236E6A51-AF61-485E-A551-C2C6DA791AD3Q26827450-1F446456-4740-44A5-91D0-00245141A7A0Q26852498-87FD2AC6-278E-4B58-B845-528BD00E4F4BQ26865248-DF011DA9-FCE9-4984-A7E9-C6FFCA9CB9F0Q26991735-29E4155B-99B1-466A-B5A5-5F55E52CF06CQ26997401-874A107D-97A2-4B4E-B587-DAF1E883094BQ27014882-B6B67045-98FE-427B-BF2A-CEBD8CF337F4Q27015033-49E55688-7E56-420E-BC1A-727F5BFE84C4Q27314804-F78A3075-3B42-4E37-AE0C-E6EA117B60CDQ27497351-F41F6B40-CFA5-48EE-90C2-A64AB02087E9Q28079736-F09C4099-2C72-4668-BD44-D910DE1829CCQ28083001-FC156D98-3981-437B-809E-D11DE3D26F29Q28246421-F575DB44-D310-4032-AF7C-34A6307F56B8Q28354293-48E4358D-FF76-42C5-A6CF-B63117733A8AQ28384001-F86C2082-95F9-4779-BF2D-93F6361A5CCFQ28396747-A817F900-E41A-4E07-B33A-9A0011AB71EFQ28474576-80BAC8FE-B927-41D5-87CA-E24922A70003Q28476015-2E4FA44E-584D-416E-84A1-9529882452E9Q28477621-F43FAF0E-DE54-4D03-B5D4-5C40E081A518Q28479029-6B19F84A-5F9B-432C-A90D-DD8B156418B4Q28537870-A1D0F5C4-199C-4638-AE91-5CFBF5A85BB0Q28541267-F36D96D0-6C03-4282-8968-EC40C582DB2CQ28547562-3758E3C2-8168-4A60-B9E2-14197E4BB903Q28576077-8B33C531-A76E-4821-BA3C-10C71B6DC940Q28578504-0A5DFB9C-EF40-43F1-A56B-1450632E09F1Q28586093-4DF9C55D-6274-4043-B888-49D536A18C6BQ28586911-4611F56C-380E-4AAA-94C1-1037723844A7Q28728727-94E0354D-DE12-44C9-8EE1-E01018981491Q29302398-05784AE3-06F2-45B8-9548-41AF81E7D579Q30248578-34010973-344E-4563-94B0-7A66B888F8B7Q30248650-7B8B3ACF-1931-435A-BE2D-051F39C9CD1AQ30586373-F14A6512-9284-44AA-9C76-57A2997F07E5Q30620446-1AF33D90-A1BF-4F87-A3FF-C52D2E46F186
P2860
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Contribution of de novo fatty ...... m genetically engineered mice.
@ast
Contribution of de novo fatty ...... m genetically engineered mice.
@en
type
label
Contribution of de novo fatty ...... m genetically engineered mice.
@ast
Contribution of de novo fatty ...... m genetically engineered mice.
@en
prefLabel
Contribution of de novo fatty ...... m genetically engineered mice.
@ast
Contribution of de novo fatty ...... m genetically engineered mice.
@en
P2860
P356
P1476
Contribution of de novo fatty ...... m genetically engineered mice.
@en
P2093
Catherine Postic
Jean Girard
P2860
P304
P356
10.1172/JCI34275
P407
P577
2008-03-01T00:00:00Z